Notice of Intent to Award a Sole Source Contract to Hitachi

The Food and Drug Administration intends to award a sole source firm-fixed price commercial purchase order to Hitachi for a high voltage pump that serves as a direct replacement part for the Hitachi SU6600 Field Emission Scanning Electron Microscope. This procurement is justified under FAR 6.302-1 because Hitachi is the only manufacturer capable of producing the component that meets the exact technical specifications and integrates seamlessly with the existing SU6600 system, which is critical for analyzing criminal and public health samples. The acquisition is not open to competitive bidding, and the notice explicitly states that it is not a request for competitive quotes, but other firms may submit a capability statement demonstrating their ability to meet the requirements by June 19, 2026, to Janice Heard at janice.heard@fda.hhs.gov. The contract will be administered under FAR Part 12 as a commercial purchase order, with performance required in Cincinnati, Ohio, and the contracting office located in Rockville, Maryland. No set-aside provisions are applicable, and no contract value, delivery schedule, or detailed inspection criteria are specified in the notice. The purchasing activity is categorized under NAICS code 334516, related to other electronic component manufacturing, and no additional technical, packaging, or administrative details have been released beyond the scope of the sole-source justification and submission window for alternatives.